Kenvue Inc. (NYSE: KVUE) announced that it will publish its fourth‑quarter and full‑year 2025 financial results after market close on February 17, 2026. The company will not hold a conference call to discuss the results, citing the pending merger with Kimberly‑Clark.
The earnings release follows a strong Q3 2025 performance, where adjusted diluted earnings per share rose to $0.28 from $0.26 in Q4 2024, while revenue climbed to $3.76 billion from $3.66 billion. The 3.5% year‑over‑year revenue growth was driven by robust demand in the Skin Health and Beauty and Self‑Care segments, offset by a 2.1% decline in the Essential Health line.
Analysts had expected Q4 2025 earnings of $0.22 per share and revenue of $3.71 billion. Kenvue’s guidance for the full year remains $1.00–$1.05 EPS, with a flat to 2% year‑over‑year growth in adjusted EPS, reflecting confidence in continued brand investments and cost discipline.
Management highlighted that the pending acquisition of Kenvue by Kimberly‑Clark, approved by shareholders on January 29, 2026, is a key factor in the decision to forego a conference call. CEO Thibaut Mongon said the merger “strengthens our global footprint and positions us to accelerate growth while maintaining operational excellence.”
The company’s gross profit margin expanded 80 basis points in Q4 2024 to 45.2%, driven by higher mix of high‑margin beauty products and improved supply‑chain efficiencies. However, adjusted operating income margin contracted 30 basis points to 12.5% due to increased raw‑material costs and investment in marketing for the upcoming merger.
Investors and analysts will watch the February 17 release for confirmation of the company’s guidance, the impact of the merger on earnings quality, and any adjustments to the full‑year outlook that could influence long‑term valuation.
The content on EveryTicker is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.